Share

Constructive Disruption in Diabetes

In its inaugural event, the Disrupt Diabetes Design Challenge brought together new perspectives to tackle persistent challenges diabetes with a human-first, design-centric approach. A mechanical engineer is sitting in a conference room at Stanford University. At the table, he is joined by an emergency medicine clinical pharmacist and healthcare designer. Across from them sit two...
Share

Analysis Estimates the Positive Impact of Empagliflozin on Life Expectancy in Adults with Type 2 Diabetes and Established Cardiovascular Disease

Treatment with empagliflozin may positively impact life expectancy in adults with type 2 diabetes and established cardiovascular disease, according to results from the EMPA-REG OUTCOME trial recently published in Circulation. Using actuarial methods and assuming that the demonstrated beneficial effects of empagliflozin remain consistent with long-term use, empagliflozin was estimated to extend life expectancy by one...
Share

Aflibercept Injection Improved Diabetic Retinopathy and Reduced Vision-Threatening Complications in Phase 3 Trial

The Phase 3 PANORAMA trial evaluating aflibercept injection in patients with moderately severe and severe non-proliferative diabetic retinopathy (NPDR) met its one-year (52-week) primary endpoint and key secondary endpoints, the drug’s manufacturer announced today. Regeneron Pharmaceuticals is marketing the drug as EYELA. On the primary endpoint at one year, 80% and 65% of patients receiving...
Share

Midlife Women Transitioning to Menopause Have a Higher Risk of Metabolic Syndrome, Which Predisposes to Heart Disease and Type 2 Diabetes

Multi-ethnic study shows midlife women with more physical activity or a lower calorie diet have less risk of developing the disease Midlife women transitioning to menopause may be able to lower their risk of developing heart disease and type 2 diabetes, if they exercise more or eat a lower calorie diet, according to a new...

Diabetes Research Articles

Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.